Quarterly Results

KWALITY PHARMACEUTICALS LTD.

NSE : NABSE : 539997ISIN CODE : INE552U01010Industry : Pharmaceuticals & DrugsHouse : Private
BSE448.55-0.5 (-0.11 %)
PREV CLOSE ( ) 449.05
OPEN PRICE ( ) 443.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1794
TODAY'S LOW / HIGH ( )442.50 469.00
52 WK LOW / HIGH ( ) 248545
NSE
This Company is not listed in NSE
Quarters
Select year  
( in Million)
Particulars
Dec 2023
Sep 2023
Jun 2023
Mar 2023
Audited / UnAudited
UnAudited
Audited
UnAudited
Audited
Net Sales
780.95
696.5
674.5
688.04
Total Expenditure
614.1
544.18
536.78
573.2
PBIDT (Excl OI)
166.85
152.32
137.72
114.84
Other Income
6.18
2.34
3.96
14.6
Operating Profit
173.03
154.65
141.68
129.44
Interest
27.33
24.11
21.85
16.68
Exceptional Items
NA
NA
NA
-165.29
PBDT
145.7
130.54
119.83
-52.52
Depreciation
48.2
48.85
47.87
44.26
Profit Before Tax
97.5
81.69
71.96
-96.78
Tax
20.72
19.53
17.93
-22.79
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
76.78
62.16
54.03
-73.99
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
76.78
62.16
54.03
-73.99
Minority Interest
0.12
0.2
0.21
0.22
Shares of Associates
Other related items
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
76.9
62.36
54.23
-73.79
Equity Capital
103.76
103.76
103.76
103.76
Face Value (IN RS)
10
10
10
10
Reserves
NA
NA
NA
NA
Calculated EPS
7.41
6.01
5.22
-7.11
Calculated EPS (Annualised)
29.64
24.04
20.90
-28.44
No of Public Share Holdings
4693345
4693345
4696545
4696545
% of Public Share Holdings
45.23
45.23
45.26
45.26
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
21.36
21.86
20.41
16.69
PBIDTM%
22.15
22.20
21.00
18.81
PBDTM%
18.65
18.74
17.76
-7.63
PBTM%
12.48
11.72
10.66
-14.06
PATM%
9.83
8.92
8.01
-10.75
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.